Related Experiment Videos
A rationale for antiparasite drug discovery
1Department of Medical Parasitology, London School of Hygiene and Tropical Medicine, Keppel Street, London, UK WC I E 7HT.
Parasitology Today (Personal Ed.)
|January 1, 1994
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Leishmaniasis chemotherapy--challenges and opportunities.
Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases·2011
Kinetoplastida: new therapeutic strategies.
Parasite (Paris, France)·2008
Antimalarial efficacy and drug interactions of the novel semi-synthetic endoperoxide artemisone in vitro and in vivo.
The Journal of antimicrobial chemotherapy·2007
Recent advances in research and control of malaria, leishmaniasis, trypanosomiasis and schistosomiasis.
Eastern Mediterranean health journal = La revue de sante de la Mediterranee orientale = al-Majallah al-sihhiyah li-sharq al-mutawassit·2005
Immune effector mechanisms in parasitic infections.
Parasitology today (Personal ed.)·2006
Nitric oxide in health and disease.
Parasitology today (Personal ed.)·2006
Infection, oxford general practice series 40.
Parasitology today (Personal ed.)·2006
Parasitism and the platyhelminthes.
Parasitology today (Personal ed.)·2006
The application of attributable risk analysis in helminth epidemiology.
Parasitology today (Personal ed.)·2006
The Search for Novel Malaria Transmission-blocking Targets in the Mosquito Midgut.
Parasitology today (Personal ed.)·2006
Aptamer-based nanoparticle drug delivery system designed for targeting GPC3-positive liver cancer.
Journal of pharmaceutical analysis·2026
Structure-informed characterization of a TLR2-binding scFv reveals a CDR-centered recognition model.
Biochemical and biophysical research communications·2026
Safety assessment of the substance 1,3-benzenedicarboxamide, 5-[[[cis-4-(1,1-dimethylethyl)cyclohexyl]carbonyl]amino]-N1,N3-bis[cis-4-(1-methylethyl)cyclohexyl]- for use in food contact materials.
EFSA journal. European Food Safety Authority·2026
Systems pharmacology, structural modeling, and experimental validation reveal retinoic acid as a modulator of immune-fibrotic networks in chronic kidney disease.
Naunyn-Schmiedeberg's archives of pharmacology·2026
New paradigm of q-CAR drug development targeting disease-specific protein conformations.
npj drug discovery·2026